JEFFREY WAYNE ELDER

Allopathic & Osteopathic Physicians|Obstetrics & Gynecology|Gynecologic Oncology GREENVILLE, SC NPI 1457569923

General Payments — all program years on this page

$1,741.30

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 52
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $445.69 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $445.6920

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $340.293
2019 $211.632
2020 $233.264
2021 $151.423
2022 $46.373
2023 $312.6417
2024 $445.6920

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086920293 Novartis Pharmaceuticals Corporation $26.50 01/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086920303 Novartis Pharmaceuticals Corporation $31.05 11/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1089418654 Daiichi Sankyo Inc. $25.85 09/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1089418656 Daiichi Sankyo Inc. $23.99 12/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1089418658 Daiichi Sankyo Inc. $19.60 05/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1091966498 Ipsen Biopharmaceuticals, Inc $22.23 05/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104305994 AstraZeneca Pharmaceuticals LP $27.06 10/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105542697 AstraZeneca Pharmaceuticals LP $19.54 09/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1110751748 Eisai Inc. $24.67 02/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1110751750 Eisai Inc. $20.81 03/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1110751752 Eisai Inc. $22.56 04/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116662963 GlaxoSmithKline, LLC. $27.63 12/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120661971 Baxter Healthcare $31.94 03/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131293924 PFIZER INC. $16.59 03/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131295378 PFIZER INC. $18.79 02/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131308283 PFIZER INC. $18.09 05/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133029380 Genentech USA, Inc. $19.63 08/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137209332 INTUITIVE SURGICAL, INC. $3.72 04/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137945376 TAIHO ONCOLOGY, INC. $21.68 08/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1149315292 Dendreon Pharmaceuticals LLC $23.76 02/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.